Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months…
Two studies appearing in the October 14, 2010 New England Journal of Medicine and funded by the National Institutes of Health helped influence the World Health Organisation (WHO) to…
Nevirapine is widely used to help prevent mother-to-child transmission of the HIV virus. In cases where the infants are nonetheless infected with HIV virus at birth, the standard treatment…
Vanishing bile duct syndrome (VBDS) refers to a group of disorders characterised by destruction and disappearance of intrahepatic (inside the liver) bile ducts. Multiple causes have…
In the ongoing battle to prevent mother-to-child transmission of human immunodeficiency virus (HIV), not all weapons are being used: Only about half of HIV-exposed infants in some African…
The largest study to date to examine methods to prevent HIV infection among breastfeeding infants concludes that giving antiretroviral drugs to HIV-infected breastfeeding mothers in…
Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their foetus should not use an HIV-drug regimen that contains nevirapine for at least one year…
Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their foetus should not use an HIV-drug regimen that contains nevirapine for at least one year…
A new international study reported in PLoS Medicine confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women who receive the drug to prevent transmission…
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing…